Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Eunice S Wang

1-50 of 57 results

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

scientific article

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2

scientific article published on January 1, 1993

Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial

scientific article

Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy

scientific article

Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial

scientific article

Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502.

scientific article published on 5 November 2012

Acute Lymphoblastic Leukemia, Version 2.2015

scientific article published on October 1, 2015

Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia

scientific article published on December 21, 2010

Myelodysplastic syndromes and autoimmune diseases—Case series and review of literature

scientific article published on May 18, 2013

Treating acute myeloid leukemia in older adults

scientific article published on November 18, 2014

Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies

scientific article published on 25 February 2018

Is obesity a prognostic factor for acute myeloid leukemia outcome?

scientific article published on September 21, 2011

Molecular Epidemiology and Risk Factors for Colonization by Vancomycin-ResistantEnterococcusin Patients with Hematologic Malignancies

scientific article published on May 1, 2011

Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia

scientific article published on 10 June 2013

Revisiting the role of cladribine in acute myeloid leukemia: An improvement on past accomplishments or more old news?

scientific article published on October 25, 2014

Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy

scientific article published on January 10, 2015

Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies

scientific article published on January 11, 2016

Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia

scientific article published on April 21, 2016

Long-term response of refractory primary cold agglutinin disease to eculizumab therapy

scientific article published on May 31, 2013

Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old

scientific article published on July 1, 2015

Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia

scientific article published on 04 May 2017

Modulation of Chemotherapeutic Efficacy by Vascular Disrupting Agents: Optimizing the Sequence and Schedule

scientific article published on January 30, 2012

Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia

scientific article published on June 1, 2015

Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia

scientific article published on 22 May 2017

Clinical updates in adult acute lymphoblastic leukemia

scientific article published on December 19, 2015

Myeloid blastic transformation of myeloproliferative neoplasms—A review of 112 cases

scientific article published on August 19, 2010

Interpretation of cytogenetic and molecular results in patients treated for CML

scientific article published on March 17, 2011

Pharmacological targeting of -catenin in normal karyotype acute myeloid leukemia blasts

scientific article published on November 7, 2014

Phase 1 study of arsenic trioxide, high‐dose cytarabine, and idarubicin to down‐regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia

scientific article published on March 31, 2011

Swallowing a bitter pill–oral arsenic trioxide for acute promyelocytic leukemia

scientific article published on 03 December 2015

Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically

scientific article published on 08 February 2019

Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse

scientific article published on October 15, 2010

Development of a Preclinical PK/PD Model to Assess Antitumor Response of a Sequential Aflibercept and Doxorubicin-Dosing Strategy in Acute Myeloid Leukemia

scientific article published on 03 April 2013

Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)

scholarly article published 26 December 2018

Omacetaxine mepesuccinate in chronic myeloid leukemia

scientific article published on November 1, 2014

Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia

scientific article published on March 1, 2012

Deletion and deletion/insertion mutations in the juxtamembrane domain of the FLT3 gene in adult acute myeloid leukemia

scientific article published on October 16, 2014

NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome

Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population

scientific article published on April 26, 2011

A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia

scientific article published on February 16, 2016

Acute Myeloid Leukemia Secondary to Oxaliplatin Treatment for Esophageal Cancer

scientific article published on December 1, 2011

Early versus Late Preemptive Allogeneic Hematopoietic Cell Transplantation for Relapsed or Refractory Acute Myeloid Leukemia

scientific article published on May 24, 2014

Blinatumomab: enlisting serial killer T-cells in the war against hematologic malignancies

scientific article published on June 1, 2015

Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA

scientific article published on 05 October 2018

Smoking adversely affects survival in acute myeloid leukemia patients

scientific article published on August 2, 2011

Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia

scientific article published on 06 September 2011

Interferon-γ secretion by t(9;22) acute lymphoblastic leukemia-derived dendritic cells

scientific article published on October 12, 2010

High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure

scientific article published on July 30, 2014

Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia

scientific article published on 02 August 2019

Case study interpretation-Fort Lauderdale: Case 3

scientific article published on February 12, 2014